Profitelligence Profitelligence · Filing Ledger Open RVTY research →

Form 8-K · Current Report · Filed 2024-01-26

Revvity Announces Board Member Departure and New Appointments

On January 25, 2024, Revvity, Inc. announced that Dr. Sylvie Grégoire will not stand for re-election to the Board at the upcoming annual meeting on April 23, 2024. In connection with this, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024. Each of the new directors will receive a stock award and a grant of restricted stock units, along with a prorated annual cash retainer.

Filer
Revvity Inc. RVTY · NYSE
Filed
Accession
0001157523-24-000120
CIK
0000031791
Signal
Medium impactHealthcare

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Board Member Departure Board Member Appointed

Market reaction

Close before filing

$108.69

Next session

+1.3%

Since filing

+35.0%

Latest close

$146.73

What happened, not what will happen — closing prices around the filing date.

About Revvity Inc.

Revvity Inc. is a health science tools and diagnostics company that provides end-to-end solutions for research, development, testing, and clinical use. The company operates through two main segments: Life Sciences and Diagnostics, serving customers across pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations. Its portfolio includes reagents, consumables, assays, instruments, software, and specialized services that support workflows from discovery through diagnosis. Revvity focuses on areas such as translational multi-omics, biomarker identification, imaging, screening, detection, informatics, reproductive health, immunodiagnostics, and genomic testing. It also supports applications in rare disease testing, newborn screening, hereditary cancer, and broader clinical laboratory services. Based in Waltham, Massachusetts, Revvity plays an important role in the healthcare and life sciences ecosystem by helping researchers, clinicians, and laboratories generate and analyze data across a wide range of scientific and diagnostic applications.

Exchange NYSE Industry Diagnostics & Research Company website ↗

Never miss another RVTY filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts